Eric A. Collisson

University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center

Box 0981, UCSF

San Francisco, CA 94143-0981

United States

SCHOLARLY PAPERS

2

DOWNLOADS

79

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

A Pan-Cancer Census of Dominant Tumor Immune Archetypes

Number of pages: 99 Posted: 23 Apr 2021
University of California, San Francisco (UCSF) - UCSF CoLabs, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - ImmunoX Initiative, University of California, San Francisco (UCSF) - UCSF CoLabs, University of California, San Francisco (UCSF) - UCSF CoLabs, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, Fred Hutchinson Cancer Research Center - Translational Research Program, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, Aix-Marseille University - Centre d'Immunologie de Marseille-Luminy, University of California, San Francisco (UCSF) - UCSF CoLabs, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, Independent, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Department of Pathology, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF) - Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF) - Division of Hematology and Oncology, University of California, San Francisco (UCSF) - Department of Medicine, University of California, San Francisco (UCSF) - Department of Otolaryngology, University of California, San Francisco (UCSF) - Department of Neurological Surgery, University of California, San Francisco (UCSF) - ImmunoX Initiative, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (UCSF) - UCSF CoLabs, University of California, San Francisco (UCSF) - UCSF CoLabs, Sorbonne University - Centre d'Immunologie et des Maladies Infectieuses, University of California, San Francisco (UCSF) - Department of Epidemiology and Biostatistics, University of California, San Francisco (UCSF) - Department of Microbiology and Immunology and University of California, San Francisco (UCSF) - Department of Pathology
Downloads 56 (799,469)
Citation 1

Abstract:

Loading...

2.

In vivo Bioluminescence Imaging of Labile Iron in Xenograft Models and Liver Using FeAl-1, an Iron-Activatable Form of D-Luciferin

Number of pages: 46 Posted: 18 Nov 2022
University of California, San Francisco (UCSF) - Department of Pharmaceutical Chemistry, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, Merck & Co., Inc. - Department of Discovery Chemistry, Merck & Co., Inc. - ADME & Discovery Toxicology, Merck & Co., Inc. - ADME & Discovery Toxicology, Merck & Co., Inc. - Department of Discovery Chemistry, University of California, San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center and University of California, San Francisco (UCSF) - Department of Pharmaceutical Chemistry
Downloads 23 (1,116,535)

Abstract:

Loading...

bioluminescence imaging, chemical probes, pancreatic ductal adenocarcinoma, ferroptosis